Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation by Creteur, Jacques et al.
Available online http://ccforum.com/content/13/S5/S11
Page 1 of 7
(page number not for citation purposes)
Abstract
Introduction: The aim of this study was to evaluate the effects of
red blood cell (RBC) transfusions on muscle tissue oxygenation,
oxygen metabolism and microvascular reactivity in critically ill
patients using near-infrared spectroscopy (NIRS) technology.
Methods: This prospective, observational study included 44
consecutive patients hospitalized in the 31-bed, medical–surgical
intensive care unit of a university hospital with anemia requiring red
blood cell transfusion. Thenar tissue oxygen saturation (StO2) and
muscle tissue hemoglobin index (THI) were measured using a
tissue spectrometer (InSpectra™ Model 325; Hutchinson Tech-
nology Inc., Hutchinson, MN, USA). A vaso-occlusive test was
performed before and 1 hour after RBC transfusion by rapid
inflation of a pneumatic cuff around the upper arm. The following
variables were recorded: THI, the StO2 desaturation slope during
the occlusion (%/minute) and the StO2 upslope of the reperfusion
phase following the ischemic period (%/second). Muscle oxygen
consumption (NIR VO2; arbitrary units) was calculated as the
product of the inverse StO2 desaturation slope and the mean THI
over the first minute of arterial occlusion.
Results: Blood transfusion resulted in increases in hemoglobin
(from 7.1 (6.7 to 7.7) to 8.4 (7.1 to 9) g/dl; P <0.01) and in oxygen
delivery (from 306 (259 to 337) to 356 (332 to 422) ml/minute/
m2;  P <0.001). However, systemic VO2  was unchanged. RBC
transfusion did not globally affect NIRS-derived variables, but there
was considerable interindividual variation. Changes in the StO2
upslope of the reperfusion phase after transfusion were negatively
correlated with baseline StO2 upslope of the reperfusion phase
(r2 = 0.42; P <0.0001). Changes in NIR VO2 after transfusion were
also negatively correlated with baseline NIR VO2 (r2 = 0.48;
P = 0.0015). There were no correlations between RBC storage
time and changes in StO2 slope or NIR VO2.
Conclusions: Muscle tissue oxygenation, oxygen consumption and
microvascular reactivity are globally unaltered by RBC transfusion
in critically ill patients. However, muscle oxygen consumption and
microvascular reactivity can improve following transfusion in
patients with alterations of these variables at baseline.
Introduction
Critically ill patients often receive red blood cell (RBC)
transfusions. Studies conducted in Europe and the United
States have reported that RBC transfusions were administered
to approximately 40% of all patients [1,2], with an average of
almost 5 units of RBCs per patient; this has changed little
over the past decade [3]. Some 40 to 80% of RBC trans-
fusions in the intensive care unit (ICU) are not administered for
hemorrhage, but for low hemoglobin levels, for a decrease in
physiological reserve, or for alterations in tissue perfusion [2].
Few clinical techniques can directly monitor tissue oxygen
levels or quantify tissue oxygen consumption (VO2). The
presence of tissue hypoxia and how much transfusion is
necessary to correct the oxygen deficit are therefore still hard
to determine. It is even difficult to say whether RBC trans-
fusion really improves tissue oxygenation. In pathological
inflammatory conditions, such as sepsis or during the post-
operative period, systemic oxygenation variables do not
necessarily reflect local tissue oxygenation because of
mechanisms such as shunting or vascular dysregulation [4].
Clinical studies on the efficacy of RBC transfusion have used
different endpoints for tissue oxygenation, including systemic
VO2, blood lactate, and base excess levels [5,6]. A few
studies have demonstrated an improvement in tissue oxy-
genation after RBC transfusion associated with an increase
in oxygen delivery (DO2); other studies have not [7,8]. More
general and indirect survival measures, such as mortality,
morbidity, or length of hospital stay [1,9-11], are prone to
confounding and are difficult to influence [9].
Near-infrared spectroscopy (NIRS) has recently emerged as
a valuable tool for monitoring peripheral oxygenation in
various tissues, including the muscle. By performing a vaso-
occlusive test, a variety of NIRS-derived variables can be
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measured to assess, in particular, tissue VO2  and micro-
vascular reactivity [12].
The aim of the present study was to evaluate the effects of
RBC transfusions on muscle tissue oxygenation, VO2 and
microvascular reactivity in critically ill patients using the NIRS
technology.
Materials and methods
After approval by the ethical committee of Erasme Hospital,
informed consent was obtained from each patient’s next of
kin. This prospective study enrolled consecutive patients
hospitalized in the 31-bed Department of Intensive Care
Medicine of Erasme Hospital with anemia requiring RBC
transfusion. The indication for RBC transfusion was a hemo-
globin concentration either <8 g/dl or between 8 and 9 g/dl
in the presence of altered tissue perfusion (that is, elevated
lactate levels) or coronary artery syndromes. Exclusion
criteria were RBC transfusion in the preceding 72 hours,
peripheral vascular disease, liver cirrhosis, age <18 years,
active bleeding, and pregnancy. Hemodynamic and NIRS-
derived variables were obtained immediately before
(baseline) and 1 hour after transfusion of 1 unit packed
RBCs. During the study period, no bedside procedures
were performed, doses of vasopressor and sedative agents
were kept constant, and the patient’s position was not
changed.
Red blood cell transfusion characteristics
Packed RBC units were obtained from the blood bank of
Erasme Hospital, and were supplied by the Belgian Red
Cross. All RBC units transfused in ICU patients in our
hospital have undergone leukoreduction by filtration before
storage in a saline–adenine–glucose–mannitol solution.
The storage period can be extended up to 42 days, and
there is no blood bank policy to preferentially transfuse
fresh RBCs.
Measurements
The temperature, heart rate, arterial pressure, and central
venous pressure were recorded in all patients before and
1 hour after transfusion. In addition, complete hemodynamic
measurements were obtained in 14 patients who were
monitored with a pulmonary artery catheter. Arterial and
central venous or mixed venous blood samples were
withdrawn simultaneously, and blood gases, hemoglobin
saturation, and hemoglobin and lactate concentrations were
measured before and 1 hour after transfusion (ABL700;
Radiometer, Copenhagen, Denmark). The DO2, VO2  and
oxygen extraction ratio were calculated using standard
formulas [13]. The Acute Physiology and Chronic Health
Evaluation II score [14] was obtained at admission, and the
Sequential Organ Failure Assessment score [15] was
obtained on the study day. The length of RBC storage before
transfusion was noted in each case.
NIRS measurements and analysis
The thenar tissue oxygen saturation (StO2) and the tissue
hemoglobin index (THI), an indicator of the blood volume in
the region of the microvasculature sensed by the NIRS probe
[16,17], were measured using a tissue spectrometer
(InSpectra™ Model 325; Hutchinson Technology Inc.,
Hutchinson, MN, USA), which uses reflectance mode probes
to measure scattered light reflected at some distance from
where the light is transmitted into the tissue. The maximum
depth of the tissue sample was estimated as one-half of the
distance between the probe’s sending and receiving fibers
(probe spacing); we used a probe spacing of 25 mm. A light-
scattering calibrator was used to normalize the tissue
spectrometer during startup of the system and before each
measurement. Sample measurement signals were updated
every 3.5 seconds.
When the patient was hemodynamically stable (mean arterial
pressure >65 mmHg and no change in vasopressor doses
for 2 hours), the NIRS probe was placed on the skin of the
thenar eminence and a sphygmomanometer cuff was
wrapped around the arm over the brachial artery. After a
3-minute period necessary to stabilize the StO2 signal,
arterial inflow was stopped by inflation of the cuff to
50 mmHg above the systolic arterial pressure. After 3 minutes
of ischemia the cuff pressure was released, and StO2 was
continuously recorded for another 3 minutes (reperfusion
period). We measured the StO2 and THI continuously during
the vaso-occlusive test, and recorded the baseline StO2 and
THI before the ischemic period and the THI after 1 minute of
occlusion. During occlusion, we calculated the StO2
desaturation slope (%/minute) obtained by the regression line
of the first minute of StO2 decay after occlusion [16]. During
the reperfusion phase, we calculated the StO2 upslope of the
reperfusion phase (%/second) obtained by the regression
line of the first 14 seconds of increased StO2 (five StO2
values) following the ischemic period. This StO2 upslope of
the reperfusion phase was used to quantify the intensity of
the reactive hyperemic response following release of the
occluding cuff. The ΔStO2 upslope of the reperfusion phase
was calculated as the difference between the StO2 upslopes
of the reperfusion phase after and before transfusion. Muscle
oxygen consumption (NIR VO2) was calculated as the
product of the inverse value of the StO2 desaturation slope
and the mean THI over the first minute of arterial occlusion
[16], and is expressed in arbitrary units:
NIR VO2 = (StO2 desaturation slope–1) × 
(THIstart cuff + THI1 min)] / 2
ΔNIR VO2 (arbitrary units) was calculated as the difference
between the NIR VO2 values after and before transfusion.
Statistical analysis
Descriptive statistics were computed for all study variables.
The Kolmogorov–Smirnov test was used to verify thenormality of distribution of continuous variables. Wilcoxon’s
test was used to compare the baseline and post-transfusion
values. The relationship between NIRS-derived variables was
assessed by Spearman rank correlation. Data were analyzed
using SPSS 12.0 for Windows (SPSS, Chicago, IL, USA).
The level of statistical significance was 0.05. Data are
presented as the median (25th to 75th percentiles).
Results
The study included 44 hemodynamically stable patients, 18
of whom had sepsis (Table 1). The median ICU length of stay
was 10 (5 to 28) days, and the 28-day mortality was 27%
(Table 1). No transfusion-related adverse reaction was
observed during the study. Blood transfusion resulted in
increases in hemoglobin concentration (from 7.1 (6.7 to 7.7)
to 8.4 (7.1 to 9) g/dl; P <0.01) and in DO2 (from 306 (259 to
337) to 356 (332 to 422) ml/minute/m2;  P  <0.001). The
mean arterial pressure also increased (from 76 (70 to 83) to
80 (74 to 93) mmHg; P <0.01) (Table 2). Systemic VO2 and
NIRS-derived variables, however, were unaltered by
transfusion (Table 2).
Although RBC transfusion globally failed to affect NIRS-
derived variables (Table 2), there was considerable inter-
individual variation, with improvement in some patients and
deterioration in others. The ΔStO2 upslope of the reperfusion
phase was negatively correlated to the baseline StO2
upslope of the reperfusion phase (r2 = 0.42; P <0.0001)
(Figure 1). This negative correlation was present in septic
patients (r2 = 0.46; P = 0.0044) and in nonseptic patients
(r2 = 0.41;  P = 0.0027).  ΔNIR VO2 was also negatively
correlated to baseline NIR VO2 (r2 = 0.48;  P = 0.0015)
(Figure 2). This latter correlation was present in septic
patients (r2 = 0.56;  P <0.018) and in nonseptic patients
(r2 = 0.32; P = 0.04). ΔNIR VO2 was weakly but significantly
related to the ΔStO2 upslope of the reperfusion phase
(r2 = 0.14;  P = 0.038). There was no correlation between
baseline physiologic variables or RBC storage time and the
ΔStO2 upslope of the reperfusion phase slope or ΔNIR VO2.
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Table 1
Characteristics of the study group (n = 44 patients)
Age (years) 65 (57 to 73)
Gender, male 29 (66)
Body mass index 26 (23 to 27)
Acute Physiology and Chronic Health  15 (11 to 18)
Evaluation II score
Sequential Organ Failure Assessment score 6 (4 to 8)
Medical diagnosis 24 (54.5)
Sepsis 18 (40.9)
Intensive care unit length of stay (days) 10 (5 to 28)
Outcome, intensive care unit death 12 (27.3)
Vasopressor support 17 (38.6)
Sedative agents 15 (34.1)
Renal replacement therapy 6 (13.6)
Red blood cell storage time (days) 18 (11 to 27)
Data are presented as median (25th to 75th percentiles) or n (%).
Figure 1
Relationship between baseline and change in thenar tissue oxygen
saturation reperfusion phase upslopes. x axis: Baseline thenar tissue
oxygen saturation (StO2) upslope of the reperfusion phase
(%/second); y axis: the difference between the StO2 upslopes of the
reperfusion phase after and before transfusion (%/second). r2 = 0.42;
P <0.0001
Figure 2
Relationship between baseline muscle oxygen consumption and
change in muscle oxygen consumption. x axis: baseline muscle oxygen
consumption (NIR VO2; arbitrary units); y axis: difference in NIR VO2
after and before transfusion (ΔNIR VO2; arbitrary units). NIR VO2 was
calculated as the product of the inverse value of the thenar tissue
oxygen saturation (StO2) desaturation slope and the mean tissue
hemoglobin index over the first minute of arterial occlusion. r2 = 0.48;
P = 0.0015.Discussion
The main finding of our study was that RBC transfusion had
no consistent effect on muscle StO2, VO2, or microvascular
reactivity in critically ill patients. There was, however, con-
siderable interindividual variability. Importantly, there was a
divergent response, with an improvement in microvascular
reactivity in patients with altered microvascular reactivity at
baseline and a deterioration in microvascular reactivity in
patients with preserved baseline microvascular reactivity. The
same effect was observed for NIR VO2. The changes in NIRS
derived-variables were not related to the RBC storage time.
The effects of blood transfusions on the microcirculation and
tissue oxygenation are still poorly defined, especially in
critically ill patients. Sakr and colleagues [18] studied the
effects of RBC transfusion on the sublingual microcirculation
assessed by the orthogonal polarization spectral technique in
patients with severe sepsis. As in the present study, the
authors reported that RBC transfusion had no consistent
effect on sublingual microvascular perfusion in these septic
patients [18]. There was again considerable interindividual
variability in the response to RBC transfusions, with an
improvement in sublingual microvascular perfusion in patients
with altered perfusion at baseline and a deterioration in
sublingual microvascular perfusion in patients with preserved
baseline perfusion; these data are highly consistent with our
results.
The critical question is why some patients show beneficial
effects of RBC transfusions while others do not. Oxygenation
of the microcirculation is the result of a close interplay
between RBCs and microcirculatory vessels. If transfusion
does not improve tissue oxygenation, this could be related to
the condition of the microcirculation in the patient or to the
RBCs. Endogenous RBC deformability may be an important
factor. Indeed, RBC rheology is altered in various diseases,
including acute conditions – such as ICU patients with sepsis
or with an inflammatory reaction due to postoperative states
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Table 2
Physiologic and near-infrared spectroscopy-derived variables before and 1 hour after red blood cell transfusion
Variable Baseline After transfusion
Temperature (°C) 36.8 (36.2 to 37.5) 37 (36.4 to 37.7)
Heart rate (beats/minute) 94 (78 to 114) 94 (77 to 115)
Mean arterial pressure (mmHg) 76 (70 to 83) 80 (74 to 93)*
Central venous pressure (mmHg) 12 (9 to 16) 12 (9 to 16)
Mean pulmonary artery pressure (mmHg)a 29 (27 to 33) 30 (26 to 39)
Pulmonary artery occlusion pressure (mmHg)a 17 (15 to 18) 19 (14 to 19)
Cardiac index (l/minute/m2)a 3.0 (2.7 to 3.4) 3.1 (2.9 to 3.4)
Hemoglobin concentration (g/dl) 7.1 (6.7 to 7.7) 8.4 (7.1 to 9)*
Arterial partial pressure of carbon dioxide (mmHg) 35 (32 to 37) 35 (31 to 38)
Arterial partial pressure of oxygen (mmHg) 94 (85 to 109)  93 (84 to 113)
pH 7.45 (7.39 to 7.48) 7.44 (7.4 to 7.5)
SaO2 (%) 99 (98 to 99) 99 (98 to 99)
Lactate (mmol/l) 1.2 (0.9 to 2.2) 1.3 (0.8 to 2.1)
Mixed venous oxygen saturation (%)a 65 (51 to 72) 70 (52 to 74)
Oxygen delivery (ml/minute/m2)a 306 (259 to 337) 356 (332 to 422)*
Oxygen consumption (ml/minute/m2)a 116 (85 to 142) 118 (97 to 168)
Oxygen extraction ratio (%)a 34 (28 to 48) 28 (24 to 46)
Thenar tissue oxygen saturation (%) 90 (81 to 94) 90 (80 to 94)
Tissue hemoglobin index (arbitrary units) 14 (13 to 17) 13 (11 to 18)
Inverse thenar tissue oxygen desaturation slope (%/minute) 22 (17 to 35) 21 (16 to 32)
Thenar tissue oxygen saturation upslope of the reperfusion phase (%/second) 4.1 (2.1 to 5.4) 3.8 (2.9 to 5.1)
Muscle oxygen consumption (arbitrary units) 363 (240 to 536) 373 (215 to 500)
Data are presented as median (25th to 75th percentiles). aMeasurements obtained in 14 patients equipped with a pulmonary artery catheter.
*P <0.05 versus baseline.or intracerebral hemorrhage – or chronic conditions – such
as diabetes mellitus or terminal renal failure [19]. Friedlander
and colleagues [20] observed that RBC transfusions
improved RBC deformability in patients with sepsis, probably
by replacing rigid, endogenous RBCs by more functional, or
less dysfunctional, exogenous RBCs.
RBC storage may also be an important factor in determining
individual response to transfusion. Alterations in RBCs during
storage include a reduction in RBC deformability [21], altered
adhesiveness and aggregability, and a reduction in 2,3-
diphosphoglycerate and ATP levels [22]. These findings were
challenged by Raat and colleagues [23], however, who
reported that storage of rat RBCs for up to 5 weeks did not
alter their deformability or their oxygen-carrying properties. A
recent literature review reported no strong association
between duration of storage and complications [24]. A small
clinical study suggested an adverse effect of RBC storage on
intramucosal pH [5], but other studies failed to confirm these
findings [6,25]. In a prospective, observational trial in patients
with severe traumatic brain injury [26], transfusion of RBCs
increased cerebral oxygenation, except in patients transfused
with RBCs that had been stored for more than 19 days. The
median RBC storage time in our study was 18 days, as in
other studies [2,27], and there was no relationship between
the changes in NIRS-derived variables after transfusion and
RBC storage time.
Reactive hyperemia can be considered an integral test of
microcirculatory reactivity [28], evaluating the tissue’s ability to
adjust oxygen extraction capabilities to DO2 after a hypoxic
stimulus induced by a transient interruption of blood flow. This
process is complex, involving capillaries, arterioles, and small
arteries, increasing flow in previously patent capillaries and
recruiting additional capillaries. Hypoxic stimuli induce dilation
of precapillary arterioles, favoring the opening of closed
capillaries (recruitment) and increasing blood flow in
previously patent capillaries – a phenomenon called reactive
hyperemia. Alterations in the microcirculation have been
reported in patients with sepsis [29] and in patients with
inflammatory reactions due to postoperative states or other
diseases [30,31]. These alterations are typically characterized
by a decrease in microvascular density and an increase in the
heterogeneity of microvascular blood flow, with an increase in
intermittent or stopped flow capillaries, which could limit the
number of recruitable capillaries after a hypoxic stimulus and
thus alter the reactive hyperemia phenomenon [32].
The mechanisms that control the microvascular distribution of
capillary blood flow under hypoxic conditions are not
completely understood. The endothelium seems to play a
central role both as an oxygen sensor [33] and by inducing
vasodilatation [34] by releasing nitric oxide [33,35,36]. The
KATP channels in the vascular smooth muscle also play a
significant role in matching oxygen supply to demand during
ischemia [37]. In addition to their role as microcirculatory
components, RBCs are now considered primordial actors in
the delivery of oxygen, rather than just being oxygen
transporters. Indeed, RBCs can use hemoglobin not only as
an oxygen carrier but also as an oxygen sensor, which can
modulate tissue oxygen flow variables – by the release of the
vasodilators, nitric oxide [38,39] or ATP [40]. This release of
vasodilators from RBCs during hypoxia could be impaired
during storage. The transfusion of stored RBCs could
therefore affect microvascular reactivity to hypoxia in patients
who have preserved microvascular reactivity before
transfusion.
Transfusions may therefore be deleterious when performed in
patients with preserved deformability and/or vasoreactivity
but may be favorable when performed in patients with
markedly altered RBC deformability and/or vasoreactivity.
These findings may explain why RBC transfusion decreased
microvascular reactivity and NIR VO2 when these were
essentially normal at baseline but improved these variables
when they were already decreased at baseline. Interestingly,
RBC transfusion-induced changes in the StO2 upslope of the
reperfusion phase were related to changes in NIR VO2,
suggesting that an improvement in microvascular reactivity
(and perhaps an improvement in microvascular blood flow) is
associated with an increase in local muscle VO2.
Although there was considerable interindividual variability,
globally StO2 was not altered by RBC transfusion. There was
no relationship between baseline StO2 and the change in
StO2 after RBC transfusion. Nevertheless, the present study
was performed in hemodynamically stable patients, some-
times several days after their ICU admission. Baseline StO2
values were also in the normal range [41]. RBC transfusion
may have different effects on StO2 if given in the early phase
of resuscitation.
The THI was not altered by RBC transfusion. It is well known
that hematocrit is lower in the capillaries than in large arteries
and veins as a result of heterogeneous flow distribution, the
Fahraeus effect, and interactions between a luminal glyco-
calyx and plasma macromolecules [42-44]. In this context,
increasing the systemic hematocrit by RBC transfusion has
only limited effects on the microvascular hematocrit. Using
NIRS technology, Doerschug and colleagues showed that
the THI was not related to blood hemoglobin concentration in
patients with severe sepsis [45].
Our study has some limitations. First, the NIRS technology
itself has some limitations. StO2 represents the average of
the hemoglobin oxygen saturation in arterioles, venules, and
capillaries in the measured volume of tissue, and the relative
contributions of arterial, venous, and capillary blood within the
measured volume of tissue cannot be determined. NIRS does
not measure microcirculatory blood flow, and therefore the
increase in StO2 after temporary arterial occlusion does not
necessarily reflect the local increase in DO2 characterizing
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ments are influenced by adipose tissue thickness [46] – the
thenar eminence is therefore usually selected for NIRS
studies because the thickness of the adipose tissue covering
this muscle is less influenced by the body mass index.
Second, our measurements were restricted to 1 hour after
RBC transfusion, so we may have missed alterations that
occurred later. Our study already lasted for a total of about
2 hours (including the time needed for RBC transfusion),
however, and longer follow-up periods are practically difficult
because of inevitable changes in therapy and procedures. In
addition, spontaneous changes in the patient’s condition may
influence microcirculatory perfusion and tissue oxygenation.
Nevertheless, changes in the microcirculation are expected to
occur early after the RBC transfusion, so it is unlikely that
extending the study period would have altered our conclusions.
Conclusion
The effects of RBC transfusions on muscle oxygenation and
microvascular reactivity are quite variable and are dependent
on some baseline NIRS-derived variables. These effects
cannot be predicted from systemic hemodynamics, biological
variables, or disease severity, and are also independent of the
age of the transfused RBCs. Although further studies are
needed, the NIRS technique may represent a valuable tool to
help evaluate the effects of RBC transfusions in acutely ill
patients.
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